Potentia Pharmaceuticals Report issue

For profit Phase 1
Founded: Crestwood KY United States (2001)
Status: Acquired by Apellis Pharmaceuticals, Inc. (2014)

Organization Overview

First Clinical Trial
2007
NCT00473928
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Potentia Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

compstatin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Macular Degeneration (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1